To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle. From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage. This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence. Participants will gain insight into:

Lyophilization – or freeze drying – offers a manufacturing solution for sensitive biopharmaceuticals and vaccines that would otherwise have to rely heavily on complex cold-chain logistics during storage and transport. In this webinar recording, an expert from Thermo Fisher Scientific shares his perspectives on the value and challenges of lyophilization. Watch on demand to gain a deeper understanding of:

The use of lyophilization – or freeze drying – in the pharma manufacturing process is central to ensuring the stability and efficacy of biopharmaceuticals and vaccines for patients worldwide. Navigating the complexities of lyophilization can be tricky, and partnering with the right CDMO service providers to ensure compliance and scale-up readiness is essential. Explore the key considerations in lyophilization, with insights into:

CDMO quality performance impacts all measures of product success and improvement. Explore the key indicators of CDMO quality performance to understand its key influence on crucial aspects of pharmaceutical manufacturing. Learn how quality can accelerate time to market, reduce risk, improve return on investment, and ensure the safety and efficacy of medicines. Capture new insights into:

Changing delivery formats for sterile injectable therapies can be a valuable strategy for effectively managing the lifecycle of a drug, helping bring it to market faster, make it usable in more situations, provide cost efficiencies for the supplier, and ease medication administration to patients. Explore the considerations in making the switch, in your free white paper. Learn more about the factors in transferring delivery formats, including:

Make your successful technology transfer a reality by applying these nine key principles. Whether you are scaling up drug production, relocating to a new facility, or transitioning to a new outsourcing partner, these essential steps will help you build a plan that drives efficiency and ensures reliability – all while keeping costs down. View the infographic now to explore the critical elements for technology transfer, including:

Choosing the right plan for your biorepository facility is crucial for achieving sample integrity, adhering to compliance, driving efficiency and optimizing costs. In this latest article, explore the advantages and disadvantages of building vs. buying a biorepository, and learn the importance of aligning the decision with your unique needs.

Cell and gene therapies (CGTs) are a highly promising and evolving field of therapeutic development. Regulatory bodies, such as the FDA, are facilitating and expediting regulatory programs, to support and speed up CGT development. However, the success of CGT commercialization also demands efficient supply chain management. To learn more about how effective supply chain management can lead to success, explore insights on:

The biologics industry is expected to continue its rapid growth, with the market predicted to reach around $240m by 2025 at an annual rate of 9.9%. As vaccines represent a large segment of expansion, the demand for seamless and efficient cold chain management has never been more critical. Thermo Fisher Scientific explore the pivotal role of their expert end-to-end services, including: